Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Net Cash Flow: 2011-2025

Historic Net Cash Flow for Mimedx Group (MDXG) over the last 15 years, with Sep 2025 value amounting to $23.2 million.

  • Mimedx Group's Net Cash Flow rose 17.45% to $23.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $53.3 million, marking a year-over-year increase of 602.82%. This contributed to the annual value of $23.3 million for FY2024, which is 3.58% down from last year.
  • As of Q3 2025, Mimedx Group's Net Cash Flow stood at $23.2 million, which was up 86.64% from $12.4 million recorded in Q2 2025.
  • Over the past 5 years, Mimedx Group's Net Cash Flow peaked at $23.2 million during Q3 2025, and registered a low of -$32.7 million during Q1 2024.
  • Over the past 3 years, Mimedx Group's median Net Cash Flow value was $12.8 million (recorded in 2023), while the average stood at $7.7 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first tumbled by 1,316.09% in 2022, then spiked by 10,440.40% in 2024.
  • Over the past 5 years, Mimedx Group's Net Cash Flow (Quarterly) stood at -$11.4 million in 2021, then skyrocketed by 36.34% to -$7.3 million in 2022, then surged by 97.92% to -$151,000 in 2023, then soared by 10,440.40% to $15.6 million in 2024, then grew by 17.45% to $23.2 million in 2025.
  • Its last three reported values are $23.2 million in Q3 2025, $12.4 million for Q2 2025, and $2.0 million during Q1 2025.